Tackling autoimmunity with nanomedicines.

Nanomedicine
Xiangru FengJianxun Ding

Abstract

Tolerogenic immunotherapy aims to blunt pathogenic inflammation without affecting systemic immunity. However, the anti-inflammatory drugs and immunosuppressive biologics that are used in the clinic usually result in nonspecific immune cell suppression and off-target toxicity. For this reason, strategies have been developed to induce antigen-specific immune tolerance through the delivery of disease-relevant antigens by nanocarriers as a benefit of their preferential internalization by antigen-presenting cells. Herein, we discuss the recent advances in the nanotechnology-based antigen-specific tolerance approaches. Some of these designs are based on nanoparticles delivering antigens and immunoregulatory agents to modulate antigen-presenting pathways, while others directly target T cells via nanoparticle-based artificial antigen-presenting cells. These antigen-specific therapies are hoped to replace systemic immune suppression and provide long-term disease remission.

References

Jan 7, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·C L VanderlugtS D Miller
Sep 19, 2001·The Journal of Experimental Medicine·D HawigerM C Nussenzweig
Jan 5, 2002·Expert Opinion on Investigational Drugs·Susan Lightman, Howesen Kok
Feb 14, 2003·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Marcela V MausCarl H June
Apr 13, 2006·Nano Letters·B Devika ChithraniWarren C W Chan
Dec 19, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anton Y PelegDavid L Paterson
Feb 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Danielle M Turley, Stephen D Miller
Sep 18, 2007·Nature Biotechnology·Sai T ReddyJeffrey A Hubbell
Sep 22, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Vaibhav DubeyN K Jain
Apr 5, 2008·European Journal of Immunology·Vania ManolovaMartin F Bachmann
Nov 13, 2008·Proceedings of the National Academy of Sciences of the United States of America·Gabriela SentiThomas M Kündig
Dec 8, 2009·Autoimmunity Reviews·Ana LleoM Eric Gershwin
Aug 28, 2010·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·Simon R J TaylorSue Lightman
Oct 16, 2010·Nature Reviews. Immunology·Martin F Bachmann, Gary T Jennings
Nov 12, 2010·Proceedings of the National Academy of Sciences of the United States of America·Francisco J QuintanaHoward L Weiner
Aug 9, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Daniel R GettsStephen D Miller
Sep 8, 2011·Proceedings of the National Academy of Sciences of the United States of America·Christopher M JewellDarrell J Irvine
Jun 30, 2012·Proceedings of the National Academy of Sciences of the United States of America·Ada YesteFrancisco J Quintana
Sep 20, 2012·Journal of Hepatology·Antonella CarambiaJohannes Herkel
Nov 28, 2012·International Journal of Clinical Practice. Supplement·I Bjarnason
Jun 7, 2013·Science Translational Medicine·Andreas LutterottiRoland Martin
Jul 26, 2013·Nature Reviews. Immunology·Douglas M SmithJames R Baker
Oct 24, 2013·Nature Materials·Darrell J IrvineGregory L Szeto
Jan 11, 2014·Immunology Letters·Xavier Clemente-Casares, Pere Santamaria
Jan 17, 2014·Science Translational Medicine·Daniel R GettsNicholas J C King
Feb 5, 2014·Journal of Nanobiotechnology·Li ShangGerd Ulrich Nienhaus
Mar 22, 2014·European Journal of Immunology·Hans Christian ProbstHansjörg Schild
May 7, 2014·Journal of Hepatology·Antonella CarambiaJohannes Herkel
May 9, 2014·Clinical Reviews in Allergy & Immunology·Annarosa FloreaniM Eric Gershwin
Dec 3, 2014·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Patrícia SeverinoEliana B Souto
Dec 24, 2014·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Joana F FangueiroEliana B Souto
Dec 31, 2014·Proceedings of the National Academy of Sciences of the United States of America·Roberto A MaldonadoTakashi Kei Kishimoto
Jan 18, 2015·Nanomedicine : Nanotechnology, Biology, and Medicine·Marjan GharagozlooMarianna Foldvari
Feb 24, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Pau Serra, Pere Santamaria
Jun 20, 2015·Trends in Immunology·Daniel R GettsNicholas J C King
Feb 18, 2016·Nature·Xavier Clemente-CasaresPere Santamaria

❮ Previous
Next ❯

Citations

Jan 5, 2021·Frontiers in Pharmacology·Zhilong ZhaoCongxiao Zhang
Dec 18, 2020·Frontiers in Bioengineering and Biotechnology·Jie LiChangfeng Fu
Apr 2, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Gi Beom KimIn-San Kim
Mar 29, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Fei WangGang Chen

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT03486990

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.